Progestogens: effects on clinical and biochemical parameters in postmenopausal women.
Archer
David F
DF
D000279:Administration, Cutaneous; D000568:Amenorrhea / Q000453:epidemiology; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D004394:Dydrogesterone / Q000627:therapeutic use; D004717:Endometrium / Q000000981:diagnostic imaging; D004958:Estradiol / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008535:Megestrol / Q000627:therapeutic use; D009649:Norpregnadienes / Q000627:therapeutic use; D017698:Postmenopause; D011374:Progesterone / Q000627:therapeutic use; D014463:Ultrasonography; D014592:Uterine Hemorrhage / Q000139:chemically induced*
D003271:Contraceptive Agents, Female; D009649:Norpregnadienes; D011374:Progesterone; D004958:Estradiol; C038501:nomegestrol acetate; D004394:Dydrogesterone; D017258:Medroxyprogesterone Acetate; D008535:Megestrol